Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia:No long-term cardiac damage in a randomized study of the Dutch Childhood Leukemia Study Group

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions